Comparison of Clinical Features in Hla-B27 Positive and Negative Patients with Axial Spondyloarthritis

Hassan Shaukat; Amer Fakhr; Zohra Tasleem; Ghulam Abbas Niazi; Amina Khurshid; Farzana Hakim

doi:10.51253/pafmj.v75i6.10379

Authors

Hassan Shaukat Department of Rheumatology, Pak Emirates Military Hospital/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Amer Fakhr Department of Rheumatology, Pak Emirates Military Hospital/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Zohra Tasleem Department of Hematology, Combined Military Hospital/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Ghulam Abbas Niazi Department of Rheumatology, Pak Emirates Military Hospital/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Amina Khurshid Department of Rheumatology, Pak Emirates Military Hospital/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Farzana Hakim Department of Biochemistry, Foundation University, Islamabad Pakistan

DOI:

https://doi.org/10.51253/pafmj.v75i6.10379

Keywords:

Axial Spondyloarthritis, HLA-B27, Rheumatology

Abstract

Objective: To compare the clinical features of HLA-B27 positive and negative patients having axial spondyloarthritis.

Study Design: Qusai-experimental study.

Place and Duration of Study: Department of Rheumatology, Pak Emirates Military Hospital (PEMH), Rawalpindi Pakistan, from Oct 2022 to Apr 2023.

Methodology: Patients with axial spondyloarthritis who were diagnosed by consultant rheumatologist on the basis of Assessment of Spondyloarthritis International Society were recruited. All baseline investigations and HLA typing were performed on the study participants. They were further divided into two groups for comparison on the basis of HLA-B27 positivity or negativity. Relevant clinical features were compared in both the groups.

Results: A total of 150 patients of axial spondyloarthritis were recruited in this study, with mean age being 42.78±10.2 years, among whom 41(27.3%) patients were female while 109(72.7%) were male, while 104(69.3%) patients of axial spondyloarthritis were HLA-B27 positive and 46(30.7%) were HLA-B27 negative. It was noted that positive family history of axial spondyloarthritis, hip joint involvement, uveitis, inadequate response to NASAIDs and good response to biological therapy were statistically significant among patients who were HLA-B27 positive as compared to those who were HLA-B27 negative.

Conclusion: Positive family history, hip joint involvement, uveitis, inadequate response to NASAIDs and good response to biological therapy was noted among patients who were HLA-B27 positive.

Downloads

Download data is not yet available.

References

1. Khan SEA, Saeed MA, Batool S, Farman S, Ahmad NM, Hasni SA. A rheumatology curriculum in Pakistan for empowering family physicians and fighting disability. Clin Rheumatol 2020; 39(3): 681-687.

https://doi.org/10.1007/s10067-019-04797-7

2. Winkler AE, Miller M. Update on axial spondyloarthritis. Mo Med 2022; 119(1): 79-83.

3. Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos S, et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 2023; 82(1): 19-34.

https://doi.org/10.1136/ard-2022-223296

4. Wampler Muskardin TL, Paredes JL, Appenzeller S, Niewold TB. Lessons from precision medicine in rheumatology. Mult Scler 2020; 26(5): 533-539.

https://doi.org/10.1177/1352458519884249

5. Wysocki T, Olesińska M, Paradowska-Gorycka A. Current understanding of an emerging role of HLA-DRB1 gene in rheumatoid arthritis: From research to clinical practice. Cells 2020; 9(5): 1127.

https://doi.org/10.3390/cells9051127

6. Coates LC, Baraliakos X, Blanco FJ, Blanco-Morales EA, Braun J, Chandran V, et al. The phenotype of axial spondyloarthritis: Is it dependent on HLA-B27 status? Arthritis Care Res (Hoboken) 2021; 73(6): 856-860.

https://doi.org/10.1002/acr.24174

7. Lim CSE, Sengupta R, Gaffney K. The clinical utility of human leucocyte antigen B27 in axial spondyloarthritis. Rheumatology (Oxford) 2018; 57(6): 959-968.

https://doi.org/10.1093/rheumatology/kex345

8. Arévalo M, Gratacós Masmitjà J, Moreno M, Calvet J, Orellana C, Ruiz D, et al. Influence of HLA-B27 on the ankylosing spondylitis phenotype: Results from the REGISPONSER database. Arthritis Res Ther 2018; 20(1): 221.

https://doi.org/10.1186/s13075-018-1724-7

9. Arévalo Salaet M, López-Medina C, Moreno M, Navarro-Compán V, Fontova JC, Llop M, et al. Association between HLA-B27 and peripheral spondyloarthritis phenotype: Results from the ASAS perSpA study. RMD Open 2022; 8(2): e002696.

https://doi.org/10.1136/rmdopen-2022-002696

10. Lodhi NA, Bashir MM, Tipu HN, Hussain M. Distribution of HLA-B*27 subtypes in patients with ankylosing spondylitis in local population. J Coll Physicians Surg Pak 2019; 29(5): 418-421. https://doi.org/10.29271/jcpsp.2019.05.418

11. Glintborg B, Sørensen IJ, Østergaard M, Dreyer L, Mohamoud AA, Krogh NS, et al. Ankylosing spondylitis versus nonradiographic axial spondyloarthritis: Comparison of tumor necrosis factor inhibitor effectiveness and effect of HLA-B27 status: An observational cohort study from the nationwide DANBIO registry. J Rheumatol 2017; 44(1): 59-69.

https://doi.org/10.3899/jrheum.160958

12. Walsh JA, Magrey M. Clinical manifestations and diagnosis of axial spondyloarthritis. J Clin Rheumatol 2021; 27(8): e547-e560.

https://doi.org/10.1097/RHU.0000000000001575

13. Chou YC, Er TK. High-throughput and automated detection of HLA-B*27 using the LabTurbo AIO system. Biomedicines 2023; 11(3): 986. https://doi.org/10.3390/biomedicines11030986

14. Salaffi F, Siragusano C, Alciati A, Cassone G, D’Angelo S, Guiducci S, et al. Axial spondyloarthritis: Reshape the future: From the “2022 GISEA International Symposium”. J Clin Med 2022; 11(24): 7537. https://doi.org/10.3390/jcm11247537

15. Muhammad S, Fakhr A, Manzar MA, Hakim F, Khan TA, Ahmad B. Frequency of human leucocyte antigen B27 (HLA-B27) in clinically diagnosed axial spondyloarthritis: A study of 100 cases. Pak Armed Forces Med J 2019; 69(6): 1194-1198.

16. Rosenbaum JT, Weisman MH, Hamilton H, Shafer C, Aslanyan E, Howard RA, et al. HLA-B27 is associated with reduced disease activity in axial spondyloarthritis. Sci Rep 2021; 11(1): 12331. https://doi.org/10.1038/s41598-021-91829-5

17. Ding Y, Xue L. HLA-B27 negative reactive arthritis versus HLA-B27 positive reactive arthritis: A retrospective study. Medicine (Baltimore) 2022; 101(35): e30383.

https://doi.org/10.1097/MD.0000000000030383

18. Zhang S, Wang Y, Peng L, Su J, Zeng X, Li M, et al. Comparison of clinical features in HLA-B27-positive and HLA-B27-negative patients with axial spondyloarthritis: Results from a cohort of 4,131 patients. Front Med (Lausanne) 2020; 7: 609562. https://doi.org/10.3389/fmed.2020.609562